2015-01-27 18:18:43

BIOMED-LUBLIN (Resolution No. 95/2015)

Resolution No. 95/2015
of the Management Board of the Warsaw Stock Exchange
dated 26 January 2015

concerning the introduction to exchange trading in the WSE Main List of
series B, C, D and E bearer ordinary shares of the company
"BIOMED-LUBLIN" WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A.

§ 1

Pursuant to § 38.1 and § 38.3 of the WSE Rules and § 2.1 of Division 4 of the Detailed Exchange Trading Rules in UTP, the WSE Management Board resolves as follows:

1) to introduce as of 30 January 2015 by way of an ordinary procedure to exchange trading in the main market the following bearer ordinary shares of the company "BIOMED-LUBLIN" WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A. a par value PLN 0.10 each, coded as "PLBMDLB00018" by the National Depository for Securities:

a) 5,012,853 series B shares,
b) 848,330 series C shares,
c) 7,712,080 series D shares,
d) 5,700,000 series E shares;

2) to list the shares of the company "BIOMED-LUBLIN" WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A., mentioned in point 1), in the continuous trading system under the abbreviated name "BIOMEDLUB" and the code "BML".

§ 2

This Resolution shall take effect on the date of adoption.

distributed by